Literature DB >> 16041215

Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis.

Patrick G Northup1, Ryan C Wanamaker, Vanessa D Lee, Reid B Adams, Carl L Berg.   

Abstract

OBJECTIVE: We sought to determine the ability of the Model for End-Stage Liver Disease (MELD) score to predict 30-day postoperative mortality for patients with cirrhosis undergoing nontransplant surgical procedures. SUMMARY BACKGROUND DATA: The Child-Pugh class historically has been used by clinicians to assist in management decisions involving patients with cirrhosis. However, this classification scheme has a number of limitations. Recently, MELD was introduced. It has been shown to be highly predictive of mortality in a variety of clinical scenarios.
METHODS: Adult patients with a diagnosis of cirrhosis undergoing nontransplant surgical procedures between January 1, 1996, and January 1, 2002, at a single center were analyzed. The preoperative MELD score was calculated for all patients, and the MELD's performance in predicting 30-day mortality was determined using multivariate regression techniques.
RESULTS: A total of 140 surgical procedures were identified and analyzed. The 30-day mortality rate was 16.4%. The mean admission MELD score for the patients who died (23.3, 95% confidence interval 19.6-27.0) was significantly different from those patients surviving beyond 30 days (16.9, 15.6-18.2), P = 0.0003. The c-statistic for MELD score predicting 30-day mortality was 0.72. Further subgroup analysis of 67 intra-abdominal surgeries showed an in-hospital mortality of 23.9%. The mean MELD score for patients dying (24.8, 20.4-29.3) was significantly different from survivors (16.2, 14.2-18.2), P = 0.0001. The c-statistic for this subgroup was 0.80.
CONCLUSIONS: The MELD score, as an objective scale of disease severity in patients with cirrhosis, shows promise as being a useful preoperative predictor of surgical mortality risk.

Entities:  

Mesh:

Year:  2005        PMID: 16041215      PMCID: PMC1357730          DOI: 10.1097/01.sla.0000171327.29262.e0

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  16 in total

1.  Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease.

Authors:  L M Forman; M R Lucey
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

2.  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.

Authors:  M Malinchoc; P S Kamath; F D Gordon; C J Peine; J Rank; P C ter Borg
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

3.  The accuracy of the physical examination in the diagnosis of suspected ascites.

Authors:  E L Cattau; S B Benjamin; T E Knuff; D O Castell
Journal:  JAMA       Date:  1982-02-26       Impact factor: 56.272

4.  Prognosis and life expectancy in chronic liver disease.

Authors:  A Propst; T Propst; G Zangerl; D Ofner; G Judmaier; W Vogel
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

5.  Prognostic value of Child-Turcotte criteria in medically treated cirrhosis.

Authors:  E Christensen; P Schlichting; L Fauerholdt; C Gluud; P K Andersen; E Juhl; H Poulsen; N Tygstrup
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

Review 6.  Organ allocation: model for end-stage liver disease, Child-Turcotte-Pugh, Mayo risk score, or something else.

Authors:  Rafael Claudino Botero; Michael R Lucey
Journal:  Clin Liver Dis       Date:  2003-08       Impact factor: 6.126

7.  Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites.

Authors:  Hwan Y Yoo; David Edwin; Paul J Thuluvath
Journal:  Am J Gastroenterol       Date:  2003-06       Impact factor: 10.864

8.  Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease.

Authors:  Adnan Said; John Williams; Jeremy Holden; Patrick Remington; Ronald Gangnon; Alexandru Musat; Michael R Lucey
Journal:  J Hepatol       Date:  2004-06       Impact factor: 25.083

9.  Cholecystectomy in cirrhotic patients: a formidable operation.

Authors:  G V Aranha; S J Sontag; H B Greenlee
Journal:  Am J Surg       Date:  1982-01       Impact factor: 2.565

10.  Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis.

Authors:  Milan Sheth; Mark Riggs; Tushar Patel
Journal:  BMC Gastroenterol       Date:  2002-01-22       Impact factor: 3.067

View more
  62 in total

1.  Predictive indices of morbidity and mortality after liver resection.

Authors:  G Ercolani; Alessandro Cucchetti; Matteo Cescon; Matteo Ravaioli; Gian Luca Grazi; Antonio D Pinna
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

2.  Predictive indices of morbidity and mortality after liver resection.

Authors:  David M Nagorney; Patrick S Kamath
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

3.  The impact of cirrhosis and MELD score on postoperative morbidity and mortality among patients selected for liver resection.

Authors:  Victor M Zaydfudim; Florence E Turrentine; Mark E Smolkin; Todd B Bauer; Reid B Adams; Timothy L McMurry
Journal:  Am J Surg       Date:  2020-01-20       Impact factor: 2.565

4.  Using the Minimally Invasive Impella 5.0 via the Right Subclavian Artery Cutdown for Acute on Chronic Decompensated Heart Failure as a Bridge to Decision.

Authors:  Aditya Bansal; Jay K Bhama; Rajan Patel; Sapna Desai; Stacy A Mandras; Hamang Patel; Tyrone Collins; John P Reilly; Hector O Ventura; P Eugene Parrino
Journal:  Ochsner J       Date:  2016

5.  Model for End-Stage Liver Disease Underestimates Morbidity and Mortality in Patients with Ascites Undergoing Colectomy.

Authors:  Matthew M Fleming; Fangfang Liu; Yawei Zhang; Kevin Y Pei
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

Review 6.  Perioperative Evaluation and Management of Patients With Cirrhosis: Risk Assessment, Surgical Outcomes, and Future Directions.

Authors:  Kira L Newman; Kay M Johnson; Paul B Cornia; Peter Wu; Kamal Itani; George N Ioannou
Journal:  Clin Gastroenterol Hepatol       Date:  2019-07-31       Impact factor: 11.382

7.  Long-term results of bioprosthetic tricuspid valve replacement: an analysis of 25 years of experience.

Authors:  Naoto Morimoto; Syunsuke Matsushima; Masaya Aoki; Soichiro Henmi; Naritomo Nishioka; Hirohisa Murakami; Tasuku Honda; Keitaro Nakagiri; Masato Yoshida; Nobuhiko Mukohara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-12-06

8.  Selection criteria for liver resection in patients with hepatocellular carcinoma and chronic liver disease.

Authors:  Spiros-G Delis; Christos Dervenis
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

9.  The Hernia-Neck-Ratio (HNR), a Novel Predictive Factor for Complications of Umbilical Hernia.

Authors:  T Fueter; M Schäfer; P Fournier; P Bize; N Demartines; P Allemann
Journal:  World J Surg       Date:  2016-09       Impact factor: 3.352

10.  Value of MELD and MELD-based indices in surgical risk evaluation of cirrhotic patients: retrospective analysis of 190 cases.

Authors:  Beatriz P Costa; F Castro Sousa; Marco Serôdio; César Carvalho
Journal:  World J Surg       Date:  2009-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.